COMMUNIQUÉS West-GlobeNewswire
-
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
25/08/2025 -
OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle
25/08/2025 -
Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector
25/08/2025 -
HUTCHMED Announces Appointment of Acting Chief Executive Officer
25/08/2025
Pages